MRC funds cannabis multiple sclerosis three-year clinical trial

The pharmaceutical Journal Group

首页> 外文期刊>The pharmaceutical journal >MRC funds cannabis multiple sclerosis three-year clinical trial

【24h】

MRC funds cannabis multiple sclerosis three-year clinical trial

机译：MRC资助大麻多发性硬化症三年临床试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The Medical Research Councial is providing nearly pound1m to fund a clinical trial to assess the therapeutic effect of cannabis extract in multiple sclerosis.

机译：医学研究委员会提供了将近100万英镑来资助一项临床试验，以评估大麻提取物对多发性硬化症的治疗效果。

著录项

来源
《The pharmaceutical journal》 |1999年第7076期|共1页
作者
The pharmaceutical Journal Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. MRC funds cannabis multiple sclerosis three-year clinical trial [J] . The pharmaceutical Journal Group The pharmaceutical journal . 1999,第7076期

机译：MRC资助大麻多发性硬化症三年临床试验
2. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses [J] . Bin Sawad Aseel, Seoane-Vazquez Enrique, Rodriguez-Monguio Rosa, Current medical research and opinion . 2016,第12期

机译：扩展的残疾状态量表和多发性硬化症功能复合材料作为多发性硬化症临床试验的临床终点的评估：定量荟萃分析
3. COMPARING THE EXPANDED DISABILITY STATUS SCALE VERSUS THE MULTIPLE SCLEROSIS FUNCTIONAL COMPOSITE AS CLINICAL ENDPOINTS IN MULTIPLE SCLEROSIS CLINICAL TRIALS: A QUANTITATIVE META-ANALYSIS [J] . Bin Sawad A., Seoane-Vazquez E., Rodriguez-Monguio R., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第3期

机译：比较扩大的残疾状况量表与作为多发性硬化症临床试验中的临床终点的多发性硬化症功能性复合物：定量的荟萃分析
4. Lesion Detection, Segmentation and Prediction in Multiple Sclerosis Clinical Trials [C] . Andrew Doyle, Colm Elliott, Zahra Karimaghaloo, International workshop on brainlesion;International conference on medical imaging computing and computer-assisted intervention . 2018

机译：多发性硬化症临床试验中的病变检测，分割和预测
5. Aging and Disease-modifying Therapies in Multiple Sclerosis: Insights from Clinical Trials and Registries [D] . Zhang, Yinan. 2021

机译：多发性硬化症中的衰老和疾病改性疗法：临床试验和注册管理机构的见解
6. Clinical trials for tomorrow funded by the MRC [O] . Charles Warlow 2003

机译：由MRC资助的明天的临床试验
7. Standing up in Multiple Sclerosis (SUMS): Protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis. [O] . Freeman JA, Hendrie W, Creanor S, 2017

机译：在多发性硬化症中站立（SUMS）：一项多中心随机对照试验的协议，该试验评估了进行性多发性硬化症患者基于家庭的自我管理站立框架计划的临床和成本效益。

MRC funds cannabis multiple sclerosis three-year clinical trial

摘要

著录项

相似文献

相关主题

期刊订阅